The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
The Effect of Position (Sit/Stand up vs Supine Position) on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
1 other identifier
observational
100
1 country
1
Brief Summary
Importance of the problem OAB is a common health problem. Milsom et al. \[1\] randomly selected a population from six European countries. From this population, 17% of the respondents reported having OAB symptoms with 14% reporting frequency, 9% urgency, and 6% urge incontinence. The study by Milsom et al. \[1\] showed that OAB adversely affected the lives of the majority (65%) of the respondents who reported OAB symptoms. Chen et al. \[2\] also reported that the prevalence of OAB in Taiwanese women was similar to that of Western women. In the study of Chen et al.\[2\], the prevalence of OAB was 18.6% for the patients; perceptions and the number of OAB condition significantly increased in the elderly women (over 65 years old, 39.3%). Apart from impairing the physical health, OAB may have a tremendous effect on psychological and social well-being. Information on the symptoms and disease severity can yield important information that often complements objective measures. Incontinence, increased urge and increased frequency of micturition affect nearly 100 million people in the western world (33 million in the US and 66 million in the European Union). These conditions are not life threatening but they seriously affect quality of life and ability to work. OAB is in some studies reported to have an incidence of up to 17 % in the western population with great consequences for the quality of life. Economic cost The total economic cost of this group of conditions is high. In 2002 the costs in the US were approximately $12.7 billion\[1\] (estimated to be $17 billion and €22 billion/year in 2005). Approximately 25% of this expenditure is spent on treatment (drug therapy, clinical consultation and surgery). Of those who suffer only 28% have sought help and only half of those currently receive treatment. Less than 3% regain long lasting normal control. Therefore, these costs are an under-estimate and the problem is large. Aetiology
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2009
CompletedFirst Posted
Study publicly available on registry
January 13, 2009
CompletedStudy Start
First participant enrolled
April 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedJune 16, 2010
June 1, 2010
1.7 years
January 12, 2009
June 15, 2010
Conditions
Eligibility Criteria
The study population consists of two groups. One group consist of patients with OAB. The second group consist of volunteers without micturition complaints. (25 male \& 25 female) The second group of patients with OAB. (25 male\& 25 female) Both groups will be subjected to the exact same protocol.
You may qualify if:
- OAB must be diagnosed by their urologist using the criteria of more than 8 micturitions on three consecutive days of these three days they keep a micturation diary with a VAS score for urge sensation.
- Patients should have at least one episode of urge.
You may not qualify if:
- Patients with congestive heart disease and patients with a history of heart failure.
- Patients with a post voiding residual volume of more than 100 cc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University Hospital
Maastricht, Limburg, 6202 AZ, Netherlands
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad S Rahnama'i', MD
University hospital Maasticht
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 12, 2009
First Posted
January 13, 2009
Study Start
April 1, 2009
Primary Completion
December 1, 2010
Last Updated
June 16, 2010
Record last verified: 2010-06